Literature DB >> 24938355

An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall.

Tatsuki R Kataoka, Nobuhiro Yamashita, Ayako Furuhata, Masahiro Hirata, Takaki Ishida, Ichiro Nakamura, Seiichi Hirota, Hironori Haga1, Eiji Katsuyama.   

Abstract

Inflammatory myofibroblastic tumors (IMTs) and gastrointestinal stromal tumors (GISTs) are both spindle cell tumors, and occur rarely in the wall of the urinary bladder. In general, immunostaining allows differentiation of IMTs and GISTs. Most IMTs are positive for anaplastic lymphoma kinase (ALK) and negative for KIT, whereas most GISTs are ALK-negative and KIT-positive. Here, we describe a case of a spindle cell tumor in the wall of the urinary bladder. The spindle cells were positive for both ALK and KIT, and it was thus difficult to determine whether the tumor was an IMT or a GIST. We eventually diagnosed an IMT, because ALK gene rearrangement was confirmed by fluorescent in-situ hybridization. Cytoplasmic staining for KIT and the absence of other GIST markers, including DOG1 and platelet-derived growth factor α, indicated that the tumor was not a GIST. Therefore, IMTs should be included in the differential diagnosis of spindle cell tumors, even those that are KIT-positive.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24938355      PMCID: PMC4083143          DOI: 10.1186/1477-7819-12-186

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


Background

Inflammatory myofibroblastic tumors (IMTs) are spindle cell tumors sometimes considered to exhibit borderline malignancy [1]. These tumors are characterized by the infiltration of inflammatory cells, including lymphocytes, plasma cells, and eosinophils [1] and can occur at any site in the body, including the urinary bladder [2,3]. Approximately half of all IMTs exhibit anaplastic lymphoma kinase (ALK) gene rearrangements [4], which are considered to be an IMT marker, as are expression of vimentin, muscle-specific actin, and calponin [5-7]. The majority of IMTs do not express S-100, KIT, or CD34 [5-7]. A gastrointestinal stromal tumor (GIST) is another form of spindle cell tumor [8] that rarely occurs in the urinary bladder [9,10]. Most GISTs exhibit gain-of-function mutations in the KIT gene and express KIT protein [11,12]. KIT is a receptor-type tyrosine kinase [13] and is thus usually present in membranes, but it may also be expressed in the cytoplasm. Some GISTs lacking KIT mutations have mutations in the platelet-derived growth factor receptor α (PDGFRα) gene [14]. In such cases, PDGFRα serves as a GIST marker [14]. The DOG1 gene is also considered to be a marker of GIST [15]. Here, we describe a spindle cell tumor that developed in the wall of the urinary bladder. Immunostaining showed that the tumor cells were positive for both ALK and KIT expression, and it was thus difficult to distinguish whether the tumor was an IMT or GIST.

Case presentation

Methods

The antibodies used are listed in Tables 1 and 2. Cytological specimens were fixed in 100% methanol, and pathological specimens were fixed in formalin and paraffin-embedded. Both types of specimen were stained, as described in a previous report [16], in addition to ALK immunohistochemical staining of pathological specimens, which was performed using the intercalated antibody-enhanced polymer (iAEP) method [17].
Table 1

Antibodies used for immunostaining in immunocytochemical analyses.

AntigenCloneDilutionSourcePretreatment
SMA
1A4
Prediluted
Nichirei
None
Desmin
D33
Prediluted
Nichirei
None
Pan-cytokeratin
AE1/AE3
Prediluted
Nichirei
None
KIT
Polyclonal
1:25
DAKO
None
ALK5A4PredilutedNichireiNone

ALK, anaplastic lymphoma kinase.

Table 2

Antibodies used in immunostaining in immunohistological analyses.

AntigenCloneDilutionSourcePretreatment
SMA
1A4
Prediluted
Nichirei
None
Desmin
D33
Prediluted
Nichirei
Microwave (10 min)
Pan-cytokeratin
AE1/AE3
Prediluted
Nichirei
Protease
KIT
Polyclonal
1:25
DAKO
Microwave (10 min)
ALK
5A4
1:50
Nichirei
Boiling (30 min)*
PDGFR
Polyclonal
1:50
Santa Cruz
Boiling (60 min)
DOG1
SP31
1:50
Nichirei
Boiling (60 min)
IgG
EPR4421
1:50
Epitomics
Boiling (30 min)
IgG4HP60251:50NichireiBoiling (60 min)

* The iAEP method was required to obtain the signals. ALK, anaplastic lymphoma kinase; IgG, immunoglobulin G; PDGFR, platelet-derived growth factor receptor.

Antibodies used for immunostaining in immunocytochemical analyses. ALK, anaplastic lymphoma kinase. Antibodies used in immunostaining in immunohistological analyses. * The iAEP method was required to obtain the signals. ALK, anaplastic lymphoma kinase; IgG, immunoglobulin G; PDGFR, platelet-derived growth factor receptor. The DNA was extracted from pathological specimens. Exons 11 and 17 of the KIT gene were amplified by PCR and used for direct sequencing [18]. To explore ALK gene rearrangements, fluorescent in-situ hybridization (FISH) was performed using a Vysis ALK Break Apart FISH Probe kit (Abbott Molecular, Des Plaines, IL, USA) [19]. Briefly, unstained sections (4 μm thick) were subjected to hybridization according to the manufacturer’s protocol. ALK rearrangement was considered present when over 15% of the tumor cells displayed orange and green hybrid signals or an orange signal alone. Our patient was a 31-year-old woman initially admitted to another clinic because of painful urination and subsequently transferred to our hospital for further examination. First, we performed a cytological study of her urine and a cystoscopic examination. The cytological study did not yield any specific findings, but cystoscopy detected a submucosal tumor lying beneath the normal mucosa (Figure 1A). Computed tomography and magnetic resonance imaging identified a mass 4.5 cm in diameter in the right lateral wall of the urinary bladder (Figure 1B,C). Transurethral resection of the bladder tumor (TUR-Bt) was performed to obtain a diagnosis. Spindle cells were collected during TUR-Bt, but they did not yield any diagnostic information because of heat denaturation.
Figure 1

Cystoscopy, computed tomography, and magnetic resonance imaging findings. (A) Cystoscopy, (B) computed tomography, and (C) magnetic resonance imaging. White and yellow arrowheads indicate the submucosal tumor in the urinary bladder.

Cystoscopy, computed tomography, and magnetic resonance imaging findings. (A) Cystoscopy, (B) computed tomography, and (C) magnetic resonance imaging. White and yellow arrowheads indicate the submucosal tumor in the urinary bladder. We surgically resected the mass (Figure 2), which was located in the muscular layer of the urinary bladder, and was thus not contiguous with the mucosa. Imprint cytology was performed during resection (Figure 3A) and revealed numerous spindle cells with an abundance of cytoplasm and low nuclear atypia, admixed with infiltrating lymphocytes. Immunocytochemically, the spindle cells were negative for smooth muscle actin and desmin, but an anti-KIT antibody yielded a positive reaction (Figure 3B). However, the cells were also positive for ALK (Figure 3C). Histologically, a spindle cell tumor that was immunohistochemically positive for both KIT and ALK was also identified (Figure 4A-C). The fact that the nuclear atypia was of low grade and that a malignant component was lacking allowed us to rule out sarcomatoid cancer. We also excluded leiomyosarcoma and rhabdomyosarcoma because the tumor was negative for smooth muscle actin and desmin. In addition, staining for IgG and IgG4 indicated that the tumor was not an IgG4-related inflammatory pseudotumor, because IgG4-positive cells were very rare. A GIST was considered in differential diagnosis. We found no mutation in the KIT gene. The tumor cell cytoplasm stained weakly for KIT, which is unusual (but not unknown) for GIST tumors [11,12]. In addition, the cells were negative for other GIST markers (that is, PDGFRα and DOG1) [14,15]; therefore, we ruled out GIST. To evaluate the ALK gene status, we performed FISH analysis using the Vysis ALK Break Apart FISH Probe kit and found that approximately 20% of the signals indicated ALK gene rearrangement (Figure 4D). Thus, we diagnosed the tumor as an IMT.
Figure 2

Macroscopic findings. (A) Halved specimens. (B) Sliced specimens. Bar, 1 cm.

Figure 3

Cytological findings. (A) Papanicolaou staining. (B) KIT staining using a rabbit polyclonal antibody purchased from DAKO. (C) ALK staining using a monoclonal antibody purchased from Nichirei. All photographs were obtained at 400× magnification.

Figure 4

Histological findings. (A) H & E staining. (B) KIT staining using a rabbit polyclonal antibody purchased from DAKO. (C) ALK staining using a monoclonal antibody purchased from Nichirei. (D) FISH analysis using the Vysis ALK Break Apart FISH Probe kit. White arrowheads indicate signals positive for ALK gene rearrangements. All photographs were obtained at 200× magnification.

Macroscopic findings. (A) Halved specimens. (B) Sliced specimens. Bar, 1 cm. Cytological findings. (A) Papanicolaou staining. (B) KIT staining using a rabbit polyclonal antibody purchased from DAKO. (C) ALK staining using a monoclonal antibody purchased from Nichirei. All photographs were obtained at 400× magnification. Histological findings. (A) H & E staining. (B) KIT staining using a rabbit polyclonal antibody purchased from DAKO. (C) ALK staining using a monoclonal antibody purchased from Nichirei. (D) FISH analysis using the Vysis ALK Break Apart FISH Probe kit. White arrowheads indicate signals positive for ALK gene rearrangements. All photographs were obtained at 200× magnification. Our patient is alive and well, without recurrence, 3 years after resection.

Discussion

Most submucosal tumors in the wall of the urinary bladder are spindle cell tumors [20,21]. The spindle cell tumor in our patient expressed ALK. To the best of our knowledge, only one previous report examined the ALK status of GISTs and found that such tumors were ALK-negative [22]. However, more evidence is required to rule out a GIST, even if a spindle cell tumor is positive for ALK. ALK rearrangement is associated with the pathogenesis of various malignancies, including anaplastic large-cell lymphoma, non-small cell lung cancer, and neuroblastoma [23]. In addition, ALK rearrangement, associated with an altered enzyme expression level, is detected in approximately half of IMTs [4-7]. In the current case, we found that a significant proportion of ALK genes were split (Figure 4D). Morphological discrimination between IMT and GIST was nearly impossible in the present case, but we found that cytological examination was useful in this context. It was feasible to stain cytological specimens for ALK, and no pretreatment was required. However, we had to use a sophisticated method (iAEP method [19]) to stain the histological specimens (Table 1). Thus, cytological analysis using ALK immunostaining might be useful in differentiating an IMT from a GIST. A variety of spindle cell tumors exhibit KIT positivity, including mesothelioma [24], leiomyosarcoma [24], clear cell sarcoma [24], rhabdomyosarcoma [24], synovial sarcoma [24], angiomyolipoma [25,26], bladder urothelial carcinoma [24,27], and malignant melanoma [27]. Therefore, KIT immunopositivity alone cannot differentially diagnose a GIST among spindle cell tumors. In this case, the KIT staining pattern and the lack of PDGFRα and DOG1 immunoreactivity suggested that a GIST was unlikely. Eventually, we diagnosed the tumor as a KIT-positive IMT. Such tumors are rare, with only two cases reported in the English-language literature [2]. Interestingly, both tumors were in the urinary bladder [2]. Therefore, KIT positivity alone might not be adequate to diagnose a GIST, especially if the tumor is in the urinary bladder.

Conclusions

A possibility of IMT should be included in the differential diagnosis of KIT-positive spindle cell tumors, especially those in the urinary bladder. Molecular exploration of ALK rearrangements and KIT mutations may be required to diagnose KIT-positive spindle cell tumors.

Consent

Our patient kindly provided written informed consent for publication of this case report and the accompanying images.

Abbreviations

ALK: anaplastic lymphoma kinase; FISH: fluorescent in-situ hybridization; GIST: gastrointestinal stromal tumor; H & E: hematoxylin and eosin; iAEP: intercalated antibody-enhanced polymer; IgG: immunoglobulin G; IMT: inflammatory myofibroblastic tumor; PCR: polymerase chain reaction; PDGFRα: platelet-derived growth factor receptor α; TUR-Bt: transurethral resection of bladder tumor.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

TRK, SH, HH, and EK conceived and designed the study. NY and MH performed the immunocytochemical and immunohistochemical assays. AF performed the FISH analysis. SH screened for KIT mutations. TI and IN collected the clinical data. TRK, NY, and EK assembled the data. TRK and HH wrote the manuscript. All authors approved the final manuscript.
  27 in total

1.  TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.

Authors:  B Lawrence; A Perez-Atayde; M K Hibbard; B P Rubin; P Dal Cin; J L Pinkus; G S Pinkus; S Xiao; E S Yi; C D Fletcher; J A Fletcher
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Spindle cell tumor of urinary bladder serosa with phenotypic and genotypic features of gastrointestinal stromal tumor.

Authors:  J Lasota; J A Carlson; M Miettinen
Journal:  Arch Pathol Lab Med       Date:  2000-06       Impact factor: 5.534

3.  Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours.

Authors:  S Hirota; T Nishida; K Isozaki; M Taniguchi; J Nakamura; T Okazaki; Y Kitamura
Journal:  J Pathol       Date:  2001-04       Impact factor: 7.996

4.  Expression of KIT (CD117) in angiomyolipoma.

Authors:  Hala R Makhlouf; Helen E Remotti; Kamal G Ishak
Journal:  Am J Surg Pathol       Date:  2002-04       Impact factor: 6.394

5.  Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study.

Authors:  J R Cook; L P Dehner; M H Collins; Z Ma; S W Morris; C M Coffin; D A Hill
Journal:  Am J Surg Pathol       Date:  2001-11       Impact factor: 6.394

Review 6.  Anaplastic lymphoma kinase proteins and malignancy.

Authors:  K Pulford; S W Morris; D Y Mason
Journal:  Curr Opin Hematol       Date:  2001-07       Impact factor: 3.284

7.  Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

Authors:  Seiichi Hirota; Akiko Ohashi; Toshirou Nishida; Koji Isozaki; Kazuo Kinoshita; Yasuhisa Shinomura; Yukihiko Kitamura
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

8.  High expression of both mutant and wild-type alleles of c-kit in gastrointestinal stromal tumors.

Authors:  Nathalie Théou; Séverine Tabone; Raphael Saffroy; Axel Le Cesne; Catherine Julié; Annie Cortez; Anne Lavergne-Slove; Brigitte Debuire; Antoinette Lemoine; Jean-François Emile
Journal:  Biochim Biophys Acta       Date:  2004-04-05

9.  PD-1 regulates the growth of human mastocytosis cells.

Authors:  Tatsuki R Kataoka; Masakazu Fujimoto; Koki Moriyoshi; Itsuko Koyanagi; Chiyuki Ueshima; Fumihiko Kono; Tatsuaki Tsuruyama; Yoshimichi Okayama; Chisei Ra; Hironori Haga
Journal:  Allergol Int       Date:  2012-12-25       Impact factor: 5.836

10.  Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases.

Authors:  Melissa H Cessna; Holly Zhou; Warren G Sanger; Sherrie L Perkins; Sheryl Tripp; Diane Pickering; Clark Daines; Cheryl M Coffin
Journal:  Mod Pathol       Date:  2002-09       Impact factor: 7.842

View more
  4 in total

1.  Morphological and immunohistochemical diagnostic of extragastrointestinal stromal tumors - a 51 case series analysis.

Authors:  Valentin Tiberiu Moldovan; Oana Maria Pătraşcu; Leila Ali; Mariana Costache; Maria Sajin
Journal:  Rom J Morphol Embryol       Date:  2021 Oct-Dec       Impact factor: 0.833

2.  ALK expressed in a gastrointestinal stromal tumor harboring PDGFRA p. D842V mutation:a case report.

Authors:  Jun Fan; Ming Yang; Bo Huang; Zhenkao Wang; Danju Luo; Jiwei Zhang; Peng Zhang; Heshui Shi; Yan Li; Xiu Nie
Journal:  Diagn Pathol       Date:  2020-01-31       Impact factor: 2.644

3.  A novel fusion between CDC42BPB and ALK in a patient with quadruple wild-type gastrointestinal stromal tumor.

Authors:  Wen Huang; Wei Yuan; Lei Ren; Chen Xu; Rongkui Luo; Yuhong Zhou; Weiqi Lu; Qing Hao; Mian Xu; Yingyong Hou
Journal:  Mol Genet Genomic Med       Date:  2022-03-23       Impact factor: 2.473

4.  Inflammatory myofibroblastic tumor of urinary bladder with severe hematuria: A Case report and literature review.

Authors:  Daoqing Song; Wei Jiao; Ze Gao; Ningning Liu; Shimin Zhang; Yuqian Zong; Zhiqing Fang; Yidong Fan
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.